CARDIOMEDS MOA Flashcards
Antagonizes both β1 and β2 receptors this inhibiting effects of catecholamines on these receptors
• CV effects
Decrease contractility and heart rate
• Non-CV effects
May increase peripheral resistance
Bronchospasm
Non-selective agents
Nadolol, Pindolol, and Propranolol a
Antagonize β1 receptors to a greater extent than β2 receptors in typical doses
• CV effects
Decrease contractility and heart rate
Selective
Acebutolol, bisoprolol, esmolol, atenolol, and metoprolol a
They possess non-selective beta blocking activity like propranolol and alpha blocking activity like prazosin Effects seen: ▪ Decrease heart rate ▪ Decrease contractility ▪ Vasodilation
Alpha/beta adrenergic receptor antagonists
Labetalol, carvedilol (3rd gen. beta blockers)
o Block peripheral alpha 1 receptors → cause vasodilation secondary to inhibiting catecholamines mediated
vasoconstriction
▪ They block both arterial and venous alpha receptors
Decrease afterload of heart
Decrease peripheral vascular resistance
Selective alpha 1 adrenergic blockers
Doxazosin, prazosin, terazosin, tamsulosin (prostate selective)
Alpha 1A and 1D antagonistic effect increases selectivity for prostate
Tamsulosin
alpha 1 selective antagonist approved for BPH
Alfuzosin
Alpha 2 receptors are located in CNS→ presynaptic receptors so stimulation will decrease sympathetic outflow
Central acting alpha 2 adrenergic receptor agonist
Clonidine, guanabenz, guanfacine, methyldopa
inhibit conversion of angiotensin I to angiotensin II
Angiotensin inhibitors
ACEIs
Blocks angiotensin II from binding to the angiotensin type 1 receptor (AT1)→ blocking vasoconstriction and aldosterone
secreting effects of angiotensin II
Blocks the effect of ATII regardless of whether its generated by ACE, or some other enzymatic route
Does not interfere with metabolism of kinins and neuropeptides
Angiotensin Receptor Blockers
Metabolically converted to nitric oxide in vascular smooth muscle
vasodilating effects and reduces platelet adhesion and aggregation
Nitrates
Arteriolar vasodilator
Vasodilation causes SNS stimulation with increased heart rate and contractility, increased plasma renin activity and fluid
retention
Miscellaneous Vasodilators
Hydralazine
Venous and arteriolar vasodilator
Metabolized by smooth muscle cells to active metabolite NO → activates guanylate cyclase to form cGMP→ vasodilation
Unlike minoxidil, hydralazine, and other arteriolar vasodilators, SNP usually produces only a modest increase in HR and an overall decrease in myocardial O2 demand
Miscellaneous Vasodilators
Sodium Nitroprusside
Arteriolar vasodilator
Relaxation of smooth muscle with little effect on veins
Decrease SVR and BP by triggering SNS, inhibiting vagal tone, and renal homeostatic mechanisms leading to increase HR
CO and sodium/ fluid retention
Miscellaneous Vasodilators
Minoxidil (Rogaine)
Dopamine 1 agonist
Binds D1-like DA receptors and has moderate affinity for alpha 2 receptors (minimal adrenergic effects)
Binding D1 produces peripheral vasodilation with increase renal blood flow, diuresis and natriuresis
6x more potent than DA for renal vasodilation
Miscellaneous Vasodilators
Fenoldopam
Anti-anginal agent that doesn’t affect HR or BP
Inhibits late phase of inward sodium channel in ischemic cardiac myocytes during cardiac repolarization
Used as an additive agent after beta-blocker, nitrate and amlodipine
Miscellaneous Vasodilators
Ranolazine